SINAGRA, GIANFRANCO
 Distribuzione geografica
Continente #
EU - Europa 450
NA - Nord America 396
AS - Asia 152
OC - Oceania 2
SA - Sud America 2
Totale 1.002
Nazione #
US - Stati Uniti d'America 376
IT - Italia 191
DE - Germania 97
SG - Singapore 82
IE - Irlanda 67
GB - Regno Unito 42
CN - Cina 24
CA - Canada 20
VN - Vietnam 18
UA - Ucraina 15
SE - Svezia 13
FI - Finlandia 11
PK - Pakistan 11
IN - India 7
BE - Belgio 4
CH - Svizzera 4
HK - Hong Kong 4
AT - Austria 2
BD - Bangladesh 2
BR - Brasile 2
NZ - Nuova Zelanda 2
RU - Federazione Russa 2
IR - Iran 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
NL - Olanda 1
TR - Turchia 1
Totale 1.002
Città #
Dublin 67
Singapore 63
Chandler 60
Munich 30
San Mateo 30
Boardman 29
Milan 23
Fairfield 22
Cambridge 20
Ottawa 19
Santa Clara 16
West Jordan 16
Portsmouth 14
Stevenage 14
Krefeld 13
Rome 13
Wilmington 13
Pisa 12
Lawrence 11
Bad Bellingen 10
Dong Ket 10
Houston 10
Seattle 10
Ashburn 9
Bologna 9
Livorno 8
London 8
Beijing 7
Florence 7
Frankfurt am Main 7
Helsinki 7
New Delhi 7
Nuremberg 7
Assago 6
Mykolayiv 6
San Diego 6
Veglie 6
Woodbridge 6
Azzano San Paolo 5
Brescia 5
Washington 5
Brooklyn 4
Central District 4
Genoa 4
Lappeenranta 4
Bari 3
Castelliri 3
Parma 3
Peshawar 3
Shanghai 3
Amandola 2
Ann Arbor 2
Auckland 2
Baronissi 2
Bioggio 2
Brembate di Sopra 2
Brussels 2
Bussolengo 2
Catania 2
Ferrara 2
Fremont 2
Gozzano 2
Hanover 2
Lahore 2
Laurel 2
Lausanne 2
Multan 2
Naples 2
Nicosia 2
Palermo 2
San Mauro Pascoli 2
Scuola 2
Taranto 2
Vienna 2
Albavilla 1
Altopascio 1
Amsterdam 1
Belo Horizonte 1
Cagliari 1
Caltanissetta 1
Cambiago 1
Camden 1
Cascina 1
Contagem 1
Costa Volpino 1
Dallas 1
Desenzano del Garda 1
Forlì 1
Fuzhou 1
Hamburg 1
Hounslow 1
Islington 1
Karaganda 1
Kilburn 1
Los Angeles 1
Mainz 1
Nova Milanese 1
Padova 1
Redmond 1
Rimini 1
Totale 751
Nome #
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 127
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 85
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 78
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure 64
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test 55
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 53
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group 51
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 48
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 47
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 44
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 40
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 39
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score 37
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 36
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 31
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 23
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 21
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 19
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry 18
[Ten perspectives for research and innovation in cardiac amyloidosis] 17
Valvular heart disease in patients with cardiac amyloidosis 17
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 17
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 17
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 15
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study 15
[Transcatheter devices for chronic heart failure: state of the art] 10
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 9
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 9
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 6
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 5
Tafamidis in the Treatment of ATTR-related Cardiomyopathy 3
Totale 1.056
Categoria #
all - tutte 10.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 48 5 30 18
2021/2022174 19 25 2 19 0 6 19 25 10 28 7 14
2022/2023204 12 21 3 15 22 23 5 23 52 1 17 10
2023/2024332 10 7 39 23 5 16 13 27 43 33 33 83
2024/2025245 31 81 133 0 0 0 0 0 0 0 0 0
Totale 1.056